NVCR FY 2024 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

FY 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$605M+18.8% YoY

Gross Profit

$468M77.3% margin

Operating Income

-$170M-28.2% margin

Net Income

-$169M-27.9% margin

EPS (Diluted)

$-1.56

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$69M

Stock-Based Comp.

$160M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$881M

Stockholders' Equity

$360M

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$605M	$509M	+18.8%
Gross Profit	$468M	$381M	+22.8%
Operating Income	-$170M	-$233M	+26.8%
Net Income	-$169M	-$207M	+18.6%